LONG-TERM ALTERATIONS IN DENDRITIC SPINE STABILITY IN HUNTINGTON DISEASE: MECHANISMS UNDERLYING LEARNING DEFICITS IN HUNTINGTON DISEASE?

被引：0
|
作者：
Murmu, R. P. [1 ]
Li, J-y [1 ]
机构：
[1] Lund Univ, Wallenberg Neurosci Ctr, Lund, Sweden
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2012年 / 83卷
关键词：
D O I：
10.1136/jnnp-2012-303524.27
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A9 / A9
页数：1
相关论文
共 50 条
  • [1] Reversal of long-term dendritic spine alterations in Alzheimer disease models
    Smith, Donna L.
    Pozueta, Julio
    Gong, Bing
    Arancio, Ottavio
    Shelanski, Michael
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (39) : 16877 - 16882
  • [2] LONG-TERM MEMORY DEFICITS IN HUNTINGTON'S DISEASE: SEARCHING FOR NOVEL THERAPEUTIC TARGETS
    Alberch, J.
    Giralt, A.
    Puigdellivol, M.
    Saavedra, A.
    Gines, S.
    Perez-Navarro, E.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 255 - 255
  • [3] Characteristics of individuals with Huntington disease in long-term care
    Nance, MA
    Sanders, G
    MOVEMENT DISORDERS, 1996, 11 (05) : 542 - 548
  • [4] Long-term outcome of presymptomatic testing in Huntington disease
    Gargiulo, Marcela
    Lejeune, Severine
    Tanguy, Marie-Laure
    Lahlou-Laforet, Khadija
    Faudet, Anne
    Cohen, David
    Feingold, Josue
    Durr, Alexandra
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (02) : 165 - 171
  • [5] Long-term outcome of presymptomatic testing in Huntington disease
    Marcela Gargiulo
    Séverine Lejeune
    Marie-Laure Tanguy
    Khadija Lahlou-Laforêt
    Anne Faudet
    David Cohen
    Josué Feingold
    Alexandra Durr
    European Journal of Human Genetics, 2009, 17 : 165 - 171
  • [6] Long-term impact of Huntington disease linkage testing
    Taylor, CA
    Myers, RH
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 70 (04): : 365 - 370
  • [7] The Long-term Effect of Tetrabenazine in the Management of Huntington Disease
    Fasano, Alfonso
    Cadeddu, Federica
    Guidubaldi, Arianna
    Piano, Carla
    Soleti, Francesco
    Zinzi, Paola
    Bentivoglio, Anna Rita
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (06) : 313 - 318
  • [8] Long-term effects of olanzapine in Huntington's disease
    Wheelock, V
    Tempkin, T
    MOVEMENT DISORDERS, 2005, 20 : S10 - S10
  • [9] Association of CAG Repeats With Long-term Progression in Huntington Disease
    Langbehn, Douglas R.
    Stout, Julie C.
    Gregory, Sarah
    Mills, James A.
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A. C.
    Long, Jeffrey D.
    Owen, Gail
    Johnson, Hans J.
    Borowsky, Beth
    Craufurd, David
    Reilmann, Ralf
    Landwehrmeyer, G. Bernhard
    Scahill, Rachael I.
    Tabrizi, Sarah J.
    Acharya, Tanka
    Andrews, Sophie
    Arran, Natalie
    Axelson, Eric
    Bardinet, Eric
    Bechtel, Natalie
    Berna, Claire
    Bohlen, Stefan
    Callaghan, Jenny
    Cassidy, Amy
    Coleman, Allison
    Crawford, Helen
    Santos, Rachelle Dar
    Decolongon, Joji
    Dumas, Eve
    Fan, Mannie
    Frost, Chris
    Ghosh, Rhia
    Gibbard, Claire
    Hensman-Moss, Davina
    Hobbs, Nicola
    Jauffret, Celine
    Johnson, Eileanoir
    Jones, Rebecca
    Jurgens, Caroline
    Justo, Damian
    Keogh, Ruth
    Koren, Tamara
    Labuschagne, Izelle
    Lahiri, Nayana
    Lehericy, Stephane
    Malone, Ian
    Marelli, Cecilia
    McColgan, Peter
    JAMA NEUROLOGY, 2019, 76 (11) : 1375 - 1385
  • [10] The long-term safety of deutetrabenazine for chorea in Huntington's disease
    Frank, S.
    Vaughan, C.
    Stamler, D.
    Oakes, D.
    Davis, M.
    Eberly, S.
    Kayson, E.
    Whaley, J.
    Goldstein, J.
    Testa, C.
    MOVEMENT DISORDERS, 2017, 32
12345